On March 27, 2023, Dr. Andrew Nichols notified Astria Therapeutics, Inc. that he would resign from his position as Chief Scientific Officer of the Company, effective as of April 7, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.84 USD | +0.08% | +16.19% | +54.17% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.17% | 650M | |
+20.17% | 127B | |
+24.67% | 117B | |
+25.44% | 27.67B | |
-17.74% | 20.33B | |
-15.17% | 16.79B | |
-15.21% | 15.63B | |
+11.91% | 14.84B | |
-47.10% | 14.65B | |
+54.50% | 14.43B |
- Stock Market
- Equities
- ATXS Stock
- News Astria Therapeutics, Inc.
- Astria Therapeutics, Inc. Announces Resignation of Andrew Nichols as Chief Scientific Officer of the Company, Effective as of April 7, 2023